Home Merck's endometrial cancer drug meets late-stage trial goals byDonna Devi —May 18, 2026 0 May 18 (Reuters) - Merck said on Monday its experimental endometrial cancer drug met the main goals of a late-stage trial. Advertisement (Reporting by Kamal Choudhury in Bengaluru)
Post a Comment